Literature DB >> 12716316

Elevation of interleukin-6 levels in cervical secretions as a predictor of preterm delivery.

Melanie Lange1, Frank K Chen, Jens Wessel, Ulrich Buscher, Joachim W Dudenhausen.   

Abstract

BACKGROUND: The objective of this study was to evaluate the predictive value of interleukin-6 (IL-6) in cervical secretions for preterm delivery before 34+0 gestational weeks in patients with preterm labor.
METHODS: In this prospective study, 31 patients were enrolled with preterm labor and intact membranes. Cervical swabs were taken on admission and the concentration of IL-6 was measured. The gestational age at the time of admission and delivery, as well as the time interval to delivery, were evaluated and compared with the concentration of IL-6 on admission.
RESULTS: Cervical IL-6 was significantly elevated in the preterm delivery group (< 34+0 gestational weeks, p < 0.05). Choosing 20 pg/ml as a cut-off concentration, cervical IL-6 had a sensitivity and negative predictive value of 100%, a specificity of 67% and a positive predictive value of 47%. Concerning the time interval to delivery, the sensitivity of IL-6 was 100% and the specificity 57% for delivery within 2 days and 100% and 64% for delivery within 7 days.
CONCLUSIONS: Cervical IL-6 is a new, promising diagnostic tool to identify patients at high risk of preterm delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716316     DOI: 10.1034/j.1600-0412.2003.00149.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Interleukin 6 and fetal fibronectin as a predictors of preterm delivery in symptomatic patients.

Authors:  Marija Hadzi Lega; Ana Daneva Markova; Milan Stefanovic; Mile Tanturovski
Journal:  Bosn J Basic Med Sci       Date:  2015-01-08       Impact factor: 3.363

2.  Impact of Pregnancy History and 17-Hydroxyprogesterone Caproate on Cervical Cytokines and Matrix Metalloproteinases.

Authors:  Steve N Caritis; Gary Hankins; Mary Hebert; David M Haas; Mahmoud Ahmed; Hyagriv Simhan; Laura A Haneline; John Harris; Justine Chang; Alyssa Stephenson Famy; Patrick Yorio; Zhaoxia Ren; Mary E D'Alton; Raman Venkataramanan
Journal:  Am J Perinatol       Date:  2017-11-15       Impact factor: 1.862

3.  Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes.

Authors:  Bryan S Michalowicz; M John Novak; James S Hodges; Anthony DiAngelis; William Buchanan; Panos N Papapanou; Dennis A Mitchell; James E Ferguson; Virginia Lupo; James Bofill; Stephen Matseoane; Michelle Steffen; Jeffrey L Ebersole
Journal:  J Periodontol       Date:  2009-11       Impact factor: 6.993

4.  Concentration of lactoferrin and interleukin-6 in cervical mucus from patients being treated for infertility.

Authors:  Kaori Mitsukawa; Katsufumi Otsuki; Atsushi Yanaihara; Maki Sawada; Shinji Iwasaki; Takashi Okai
Journal:  Reprod Med Biol       Date:  2006-05-19

5.  An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Jee Yoon Park; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-15

6.  Interleukin-6 -174 genotype, periodontal disease and adverse pregnancy outcomes: a pilot study.

Authors:  M Dashash; J Nugent; P Baker; D Tansinda; F Blinkhorn
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.